Robert B. Aderholt
Trade Performance Intelligence
Score: 7/10Performance calculated from trade date to most recent market close. Real-time stock data from Financial Modeling Prep. This is not financial advice.
Stock Price at Trade vs. Today
Real market data showing how each stock moved since the congress member traded it.
Suspicious Timing Detected
1 flagThese flags identify timing coincidences between stock trades and legislative activity. They do not imply wrongdoing. Click any bill number or ticker to see the full analysis.
Share This Filing
All Transactions
Connected Legislative Activity
2 signalsThese bills and contracts share tickers or sectors with this filing's trades.
End the Vaccine Carveout Act
The 'End the Vaccine Carveout Act' removes liability protections for vaccine manufacturers, directly increasing their legal and operational risks. This bill, if enacted, will significantly alter the risk profile and profitability of pharmaceutical companies producing vaccines. Companies like Pfizer, Moderna, GSK, and Johnson & Johnson face increased litigation exposure.
Protecting Free Vaccines Act
The 'Protecting Free Vaccines Act' (HR5448) is an early-stage bill that, if enacted, would mandate no-cost coverage for ACIP-recommended vaccines by Medicare, Medicaid, CHIP, and private insurers until January 1, 2030. This would directly increase demand for vaccine manufacturers and shift cost burdens to health insurers and government programs. Vaccine manufacturers are positioned for sustained revenue growth, while health insurers face increased costs.
Live Charts
Data sourced from the U.S. House of Representatives Office of the Clerk Financial Disclosure system. Stock prices from Financial Modeling Prep. Suspicious timing flags identify coincidences between stock trades and legislative activity and do not imply any wrongdoing or illegal activity. This is not financial advice.